Abstract: This invention relates to non-steroidal compounds that are modulators of androgen receptor, and also to the methods for the making and use of such compounds.
Type:
Application
Filed:
July 1, 2009
Publication date:
October 22, 2009
Applicant:
SMITHKLINE BEECHAM CORPORATION
Inventors:
Philip Stewart Turnbull, Rodolfo Cadilla, Andrew Larkin, Huiquiang Zhou, Eugene L. Stewart, Katherine Stetson, Darryl Lynn McDougald, Amarjit Sab Randhawa, John A. Ray
Abstract: Disclosed are compounds represented by formulae I, II, and III, and the compositions and methods thereof for treating viral infections caused by a Flaviviridae family virus.
Type:
Application
Filed:
March 31, 2009
Publication date:
October 8, 2009
Applicant:
SMITHKLINE BEECHAM CORPORATION
Inventors:
Jesse Daniel Keicher, Christopher Don Roberts, Sebastian Johannes Reinhard Liehr, Xiaoling Zheng, Marija Prhavc, Vivek Kumar Rajwanshi, Ronald Conrad Griffith, Choung U. Kim
Abstract: The present invention relates to aminopyrazine derivatives, compositions and medicaments containing the same, as well as processes for the preparation and use of such compounds, compositions and medicaments. Such aminopyrazine derivatives are useful in the treatment of diseases associated with inappropriate tyrosine and/or serine/threonine kinase activity.
Type:
Grant
Filed:
October 31, 2008
Date of Patent:
October 6, 2009
Assignee:
SmithKline Beecham Corporation
Inventors:
Michael John Alberti, David Harold Drewry, David Drysdale Miller, Paul Bamborough
Abstract: Disclosed are compounds having Formula (I) and the compositions and methods thereof for treating or preventing a viral infection mediated at least in part by a virus in the Flaviviridae family of viruses, wherein A, R2, m, R, V, W, T, Z, R1, Y, and p are disclosed herein.
Type:
Grant
Filed:
December 12, 2006
Date of Patent:
September 29, 2009
Assignee:
SmithKline Beecham Corporation
Inventors:
Franz Ulrich Schmitz, Christopher Don Roberts, Ali Dehghani Mohammad Abadi, Ronald Conrad Griffith, Martin Robert Leivers, Irina Slobodov, Roopa Rai
Abstract: The present invention provides benzimidazole thiophene compounds pharmaceutical compositions containing the same, processes for preparing the same and their use as pharmaceutical agents.
Type:
Grant
Filed:
August 28, 2006
Date of Patent:
September 29, 2009
Assignee:
SmithKline Beecham Corporation
Inventors:
Mui Cheung, Kyle Allen Emmitte, James M. Salovich
Abstract: The present invention relates generally to the use of human IL-18, also known as interferon-?-inducing factor (IGIF), in the treatment of skin wounds, surgical wounds, leg ulcers, diabetic ulcers, gastrointestinal mucositis, oral mucositis, and lung injury.
Abstract: This invention relates to newly identified compounds for treating and preventing tumors and cancers, and methods for treating proliferative diseases associated with the imbalance or inappropriate activity of tyrosine kinases implicated in proliferative diseases.
Abstract: Invented is a method of inhibiting the activity/function of PI3 kinases using quinoxaline derivatives. Also invented is a method of treating one or more disease states selected from: autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, allergy, asthma, pancreatitis, multiorgan failure, kidney diseases, platelet aggregation, cancer, sperm motility, transplantation rejection, graft rejection and lung injuries by the administration of quinoxaline derivatives.
Type:
Grant
Filed:
May 8, 2008
Date of Patent:
September 22, 2009
Assignee:
SmithKline Beecham Corporation
Inventors:
Yanhong Feng, Cynthia A. Parrish, Martha A Sarpong, Domingos J Silva
Abstract: The present invention relates to compounds of formula (I), or pharmaceutically acceptable derivatives thereof, useful in the treatment of CCR5-related diseases and disorders, for example, useful in the inhibition of HIV replication, the prevention or treatment of an HIV infection, and in the treatment of the resulting acquired immune deficiency syndrome (AIDS).
Type:
Grant
Filed:
April 1, 2009
Date of Patent:
September 15, 2009
Assignee:
SmithKline Beecham Corporation
Inventors:
Michael Youngman, Wieslaw Mieczyslaw Kazmierski, Hanbiao Yang, Christopher Joseph Aquino
Abstract: The present invention relates to compounds of formula (I), or pharmaceutically acceptable derivatives thereof, useful in the treatment of CCR5-related diseases and disorders, for example, useful in the inhibition of HIV replication, the prevention or treatment of an HIV infection, and in the treatment of the resulting acquired immune deficiency syndrome (AIDS).
Type:
Grant
Filed:
December 12, 2003
Date of Patent:
September 15, 2009
Assignee:
SmithKline Beecham Corporation
Inventors:
Maosheng Duan, Wieslaw Mieczyslaw Kazmierski, Christopher Joseph Aquino
Abstract: Provided are compounds of Formula I and pharmaceutically acceptable salts thereof which may be useful for the treatment of cancer or other proliferative disorders.
Inventors:
Xiangping Qian, Luke W. Ashcraft, Jianchao Wang, Bing Yao, Hong Jiang, Gustave Bergnes, Bradley P. Morgan, David J. Morgans, Jr., Dashyant Dhanak, Steven D. Knight, Nicholas D. Adams, Cynthia A. Parrish, Kevin J. Duffy, Duke Fitch, Rosanna Tedesco
Abstract: The present invention relates to pyrazaolpyradazine derivatives that inhibit GSK3 (glycogen synthase kinase), pharmaceutical compositions containing these derivatives, and methods for their use in the treatment of disorder characterized by misregulation of GSK3.
Type:
Grant
Filed:
October 14, 2003
Date of Patent:
September 1, 2009
Assignee:
SmithKline Beecham Corporation
Inventors:
Scott Howard Dickerson, Francis Xavier Tavares, Huiqiang Zhou
Abstract: Invented is a method of inhibiting the activity/function of PI3 kinases using thiozolidinedione derivatives. Also invented is a method of treating one or more disease states selected from: autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, allergy, asthma, pancreatitis, multiorgan failure, kidney diseases, platelet aggregation, cancer, sperm motility, transplantation rejection, graft rejection and lung injuries by the administration of thiozolidinedione derivatives.
Type:
Application
Filed:
July 24, 2007
Publication date:
August 27, 2009
Applicant:
SmithKline Beecham Corporation
Inventors:
Nicholas D. Adams, Dashyant Dhanak, Steven David Knight, Lee Schaller, Jun Tang
Abstract: Disclosed are compounds, compositions and methods for treating viral infections caused by a Flaviviridae family virus, such as hepatitis C virus.
Type:
Application
Filed:
March 31, 2009
Publication date:
August 20, 2009
Applicant:
SMITHKLINE BEECHAM CORPORATION
Inventors:
Jesse Daniel Keicher, Christopher Don Roberts
Abstract: A gene (and polymorphisms within it) was associated with multiple components of the metabolic syndrome. Methods of screening subjects to identify risk of metabolic syndrome and related conditions are described, as are methods of screening compounds to identify those that act on the gene product as a target for the treatment of these conditions.
Type:
Application
Filed:
December 17, 2008
Publication date:
August 13, 2009
Applicant:
SMITHKLINE BEECHAM CORPORATION
Inventors:
Vincent Mooser, Dawn Waterworth, KiJoung Song, Xin Yuan, Christopher W. Knouff
Abstract: This invention relates to non-steroidal compounds that are modulators of androgen receptor, and also to the methods for the making and use of such compounds.
Type:
Grant
Filed:
September 27, 2007
Date of Patent:
August 11, 2009
Assignee:
SmithKline Beecham Corporation
Inventors:
Philip Stewart Turnbull, Rodolfo Cadilla, Andrew Larkin, Huiquiang Zhou, Eugene L. Stewart, Katherine Stetson, Darryl Lynn McDougald, Amarjit Sab Randhawa, John A. Ray
Abstract: Compound of formula (I): or pharmaceutically acceptable derivatives thereof, and their use as pharmaceuticals, particularly as p38 kinase inhibitors.
Type:
Grant
Filed:
April 7, 2004
Date of Patent:
August 11, 2009
Assignee:
SmithKline Beecham Corporation
Inventors:
Nicola Mary Aston, Paul Bamborough, Katherine Louise Jones, Vipulkumar Kantibhai Patel, Stephen Swanson, Ann Louise Walker